News

The results of a phase 3B study show the medication is effective treating the disorder despite only needing to be taken once every 8 weeks.

EHRs have only modestly increased their safety during a 10-year period, leaving critical deficiencies.

A new study from the University of Rochester indicates early intervention could help preserve or even restore visual abilities in stroke patients.

Researchers are continuing to learn how the COVID-19 virus will effect patients with inflammatory bowel disease.

Discussing the results of a recent analysis that estimated the impact of comprehensive therapy with SGLT2 inhibitors, ARNIs, and MRAs in patients with HFrEF.

Authors say comparing mortality rates between the 2 conditions is a threat to public health.

In a new study, investigators discover insomnia severity could predict first-onset major depressive disorder.

The new technology has applications for diagnosis and recruitment for disease-modifying trials.

The latest scientific statement from the American Heart Association examines disparities in risk factors, social determinants of health, and management approaches for these patients.

Healthcare experts can intervene earlier to help lessen the overall effects of concussion over time.

Discussing how a recently approved label update for sodium zirconium cyclosilicate impacts the treatment armamentarium of clinicians.

Historically, representation of women and minority populations is low in surgical specialties.

In an international survey, investigators discover women are more likely to suffer from a FGID than men.

In the latest edition of the DocTalk Podcast, Dr. Mark Smith talks about some of the issues related to the COVID-19 lockdown and how a second wave might psychologically impact individuals.

The findings can lead physicians to stop prescribing the drug.

Older age and higher educational level were associated with only the conditional probability of an individual treatment professional being perceived as helpful.

Investigators estimate 40-50% of proton pump inhibitor users are using inappropriately.

The biologic has now shown significant efficacy in treating 4 different atopic or type 2 inflammatory diseases.

The newest indication for the add-on biologic grants it use in children aged 6-11 years old with moderate to severe, uncontrolled atopic dermatitis.

Investigators find a greater increase in positive symptoms after a ketamine infusion when compared to placebo.

Medications can help, especially in situations where weight gain can occur at a rapid rate.

Social isolation could increase risk for cardiovascular events by 40%, according to new research presented at EAN 2020 Virtual Congress.

The findings emphasize the need to have a healthy diet and lifestyle before pregnancy.

A new analysis of 12 randomized clinical trials is shedding more definitive light on the impact of antihypertensive agents on risk of dementia and cognitive decline.

The intervention is effective, feasible, and acceptable among patients with hypertension.

Young Kim, PhD, discusses the use of a smartphone app that helps clinicians assess patients for anemia.

New research suggests combining agents from the 3 classes could pay major dividends in terms of event-free and overall survival.

An optometrist from Europe discusses the current state of glaucoma from identification to treatment.